Natural Product: NPC88454
Natural Product ID:   | NPC88454 |
Common Name*:   | Sclareol |
IUPAC Name:   | (1R,2R,4aS,8aS)-1-[(3R)-3-hydroxy-3-methylpent-4-enyl]-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-2-ol |
Synonyms:   | Sclareol |
Standard InCHIKey:   | XVULBTBTFGYVRC-HHUCQEJWSA-N |
Standard InCHI:   | InChI=1S/C20H36O2/c1-7-18(4,21)13-9-16-19(5)12-8-11-17(2,3)15(19)10-14-20(16,6)22/h7,15-16,21-22H,1,8-14H2,2-6H3/t15-,16+,18-,19-,20+/m0/s1 |
SMILES:   | C=C[C@@](C)(CC[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2CC[C@@]1(C)O)O
|
Synthetic Gene Cluster:   |
n.a. |
ChEMBL Identifier:   |
CHEMBL294740 |
PubChem CID:   |
163263 |
Chemical Classification**:   |
-
CHEMONTID:0000000 [Organic compounds]
-
[CHEMONTID:0000012] Lipids and lipid-like molecules
-
[CHEMONTID:0000259] Prenol lipids
[CHEMONTID:0001551] Diterpenoids
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
  Species Source
Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
rhizome |
n.a. |
DOI[10.1021/np100392m] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[11559179] |
NPO26969 |
Sagittaria sagittifolia |
Species |
Alismataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[16499326] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[18001808] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
Rhizomes |
n.a. |
n.a. |
PMID[20879743] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[20954721] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[21807513] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[23479199] |
NPO2618 |
Curcuma wenyujin |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
rhizome |
n.a. |
PMID[23738470] |
NPO2618 |
Curcuma wenyujin |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
root |
n.a. |
PMID[23738470] |
NPO18068 |
Curcuma phaeocaulis |
Species |
Zingiberaceae |
Eukaryota |
rhizomes |
n.a. |
n.a. |
PMID[23755850] |
NPO2618 |
Curcuma wenyujin |
Species |
Zingiberaceae |
Eukaryota |
Rhizomes |
n.a. |
n.a. |
PMID[25275213] |
NPO42003 |
A new engineered strain of Synechococcuselongatus PCC 7942 [dxs, idi] |
Strain |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
PMID[27688805] |
NPO41614 |
Corynebacterium crenatum Cc-QF-4 [argF, argA, argE] |
Strain |
Corynebacteriaceae |
Bacteria |
n.a. |
n.a. |
n.a. |
PMID[29728854] |
NPO41839 |
A new engineered strain of Corynebacterium glutamicum [ANS, 3GT] |
Strain |
Corynebacteriaceae |
Bacteria |
n.a. |
n.a. |
n.a. |
PMID[30217197] |
NPO40306 |
Psiadia arguta |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[30943031] |
NPO5326 |
Knema furfuracea |
Species |
Myristicaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[8254357] |
NPO7929 |
Curcuma zedoaria |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[9868158] |
NPO7929 |
Curcuma zedoaria |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO26969 |
Sagittaria sagittifolia |
Species |
Alismataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO6272 |
Chamaecyparis pisifera |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO6272 |
Chamaecyparis pisifera |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO26969 |
Sagittaria sagittifolia |
Species |
Alismataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO7929 |
Curcuma zedoaria |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO26969 |
Sagittaria sagittifolia |
Species |
Alismataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO7929 |
Curcuma zedoaria |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO2618 |
Curcuma wenyujin |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO2618 |
Curcuma wenyujin |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO7929 |
Curcuma zedoaria |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO18068 |
Curcuma phaeocaulis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO4903 |
Duroia hirsuta |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO2618 |
Curcuma wenyujin |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO6272 |
Chamaecyparis pisifera |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO17694 |
Nicotiana tabacum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO5326 |
Knema furfuracea |
Species |
Myristicaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO26969 |
Sagittaria sagittifolia |
Species |
Alismataceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO22741 |
Curcuma kwangsiensis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO6066 |
Graphium sarpedon |
Species |
Papilionidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO7929 |
Curcuma zedoaria |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO18068 |
Curcuma phaeocaulis |
Species |
Zingiberaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration
Organism ID |
NP ID |
Organism Material Preparation |
Organism Part |
NP Quantity (Standard) |
NP Quantity (Minimum) |
NP Quantity (Maximum) |
Quantity Unit |
Reference |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  Biological Activity
Activity Type |
# Activity |
IC50 |
12 |
Others |
11 |
Potency |
48 |
Activity Type |
# Activity |
Cell Line |
9 |
Individual Protein |
7 |
NON-MOLECULAR |
4 |
Organism |
8 |
Others |
43 |
Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT153 |
Individual Protein |
Androgen Receptor |
Homo sapiens |
Potency |
n.a. |
38895.2 |
nM |
PubChem BioAssay data set |
NPT152 |
Individual Protein |
Nuclear factor erythroid 2-related factor 2 |
Homo sapiens |
Potency |
n.a. |
76958.8 |
nM |
PubChem BioAssay data set |
NPT162 |
Individual Protein |
Heat shock protein beta-1 |
Homo sapiens |
Potency |
n.a. |
48966.2 |
nM |
PubChem BioAssay data set |
NPT163 |
Individual Protein |
Nuclear factor NF-kappa-B p105 subunit |
Homo sapiens |
Potency |
n.a. |
61644.8 |
nM |
PubChem BioAssay data set |
NPT168 |
Cell Line |
P388 |
Mus musculus |
IC50 |
= |
10.1 |
ug.mL-1 |
PMID[478538] |
NPT319 |
Cell Line |
B16 |
Mus musculus |
IC50 |
= |
28.0 |
ug.mL-1 |
PMID[478538] |
NPT788 |
Cell Line |
SNU1 |
Homo sapiens |
IC50 |
= |
11.9 |
ug.mL-1 |
PMID[478538] |
NPT737 |
Cell Line |
HUVEC |
Homo sapiens |
IC50 |
> |
50.0 |
ug.mL-1 |
PMID[478540] |
NPT393 |
Cell Line |
HCT-116 |
Homo sapiens |
IC50 |
= |
10.6 |
ug.mL-1 |
PMID[478541] |
NPT927 |
Cell Line |
PBMC |
Homo sapiens |
IC50 |
= |
10.7 |
ug.mL-1 |
PMID[478541] |
NPT66 |
Individual Protein |
Acetylcholinesterase |
Electrophorus electricus |
Inhibition |
= |
3.08 |
% |
PMID[478542] |
NPT306 |
Cell Line |
PC-3 |
Homo sapiens |
Activity |
<= |
5.0 |
% |
PMID[478543] |
NPT165 |
Cell Line |
HeLa |
Homo sapiens |
IC50 |
= |
3350.0 |
nM |
PMID[478543] |
NPT81 |
Cell Line |
A549 |
Homo sapiens |
IC50 |
= |
3210.0 |
nM |
PMID[478543] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
61644.8 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
43641.2 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
54941 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
34665.4 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
68589.6 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
43277.1 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
76958.8 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
61130.6 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
48966.2 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
19331.2 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
54482.7 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
24336.5 |
nM |
PubChem BioAssay data set |
NPT74 |
Individual Protein |
Proto-oncogene c-JUN |
Homo sapiens |
Potency |
n.a. |
43641.2 |
nM |
PubChem BioAssay data set |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
24541.2 |
nM |
PubChem BioAssay data set |
NPT16 |
Organism |
Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
= |
320000.0 |
nM |
PMID[478539] |
NPT17 |
Organism |
Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC50 |
= |
320000.0 |
nM |
PMID[478539] |
NPT4025 |
Organism |
Staphylococcus hominis |
Staphylococcus hominis |
MIC50 |
= |
320000.0 |
nM |
PMID[478539] |
NPT173 |
Organism |
Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC50 |
> |
1623000000.0 |
nM |
PMID[478539] |
NPT19 |
Organism |
Escherichia coli |
Escherichia coli |
MIC50 |
> |
1623000000.0 |
nM |
PMID[478539] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
MIC50 |
> |
1623000000.0 |
nM |
PMID[478539] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
6.0 |
ug.mL-1 |
PMID[478541] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
7.0 |
ug.mL-1 |
PMID[478541] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Inhibition |
= |
69.6 |
% |
PMID[478541] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Inhibition |
= |
70.3 |
% |
PMID[478541] |
NPT67 |
Individual Protein |
Cholinesterase |
Equus caballus |
Inhibition |
= |
-2.61 |
% |
PMID[478542] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
105.0 |
nM |
PMID[478543] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
35000.0 |
nM |
PMID[478545] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
  Chemically structural similarity: I. Similar Active Natural Products in NPASS
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC88454 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 178 |
0.1-0.2 | 2218 |
0.2-0.3 | 9293 |
0.3-0.4 | 16248 |
0.4-0.5 | 7138 |
0.5-0.6 | 5562 |
0.6-0.7 | 1730 |
0.7-0.8 | 290 |
0.8-0.85 | 32 |
0.85-0.9 | 5 |
0.9-0.95 | 0 |
0.95-1 | 3 |
  Chemically structural similarity: II. Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC88454 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 159 |
0.1-0.2 | 2758 |
0.2-0.3 | 4044 |
0.3-0.4 | 1557 |
0.4-0.5 | 328 |
0.5-0.6 | 237 |
0.6-0.7 | 67 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7215 |
Intermediate Similarity |
NPD7525 |
Registered |
0.7105 |
Intermediate Similarity |
NPD4784 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4785 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7645 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD4243 |
Approved |
0.7 |
Intermediate Similarity |
NPD6930 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD6931 |
Approved |
0.6875 |
Remote Similarity |
NPD6929 |
Approved |
0.6824 |
Remote Similarity |
NPD4751 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD7339 |
Approved |
0.6795 |
Remote Similarity |
NPD8264 |
Approved |
0.6795 |
Remote Similarity |
NPD6942 |
Approved |
0.679 |
Remote Similarity |
NPD7514 |
Phase 3 |
0.679 |
Remote Similarity |
NPD7332 |
Phase 2 |
0.6774 |
Remote Similarity |
NPD388 |
Approved |
0.6774 |
Remote Similarity |
NPD386 |
Approved |
0.675 |
Remote Similarity |
NPD7145 |
Approved |
0.6747 |
Remote Similarity |
NPD6695 |
Phase 3 |
0.6709 |
Remote Similarity |
NPD3701 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6924 |
Approved |
0.6667 |
Remote Similarity |
NPD6926 |
Approved |
0.6667 |
Remote Similarity |
NPD7338 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4195 |
Approved |
0.6625 |
Remote Similarity |
NPD6932 |
Approved |
0.6625 |
Remote Similarity |
NPD6925 |
Approved |
0.6625 |
Remote Similarity |
NPD5776 |
Phase 2 |
0.6588 |
Remote Similarity |
NPD6893 |
Approved |
0.6582 |
Remote Similarity |
NPD4190 |
Phase 3 |
0.6582 |
Remote Similarity |
NPD5275 |
Approved |
0.6579 |
Remote Similarity |
NPD4267 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD7322 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD4623 |
Approved |
0.6512 |
Remote Similarity |
NPD4519 |
Discontinued |
0.6506 |
Remote Similarity |
NPD6902 |
Approved |
0.6506 |
Remote Similarity |
NPD6898 |
Phase 1 |
0.65 |
Remote Similarity |
NPD6933 |
Approved |
0.6447 |
Remote Similarity |
NPD5361 |
Clinical (unspecified phase) |
0.6447 |
Remote Similarity |
NPD5360 |
Phase 3 |
0.6437 |
Remote Similarity |
NPD7524 |
Approved |
0.6437 |
Remote Similarity |
NPD7750 |
Discontinued |
0.641 |
Remote Similarity |
NPD7150 |
Approved |
0.641 |
Remote Similarity |
NPD7151 |
Approved |
0.641 |
Remote Similarity |
NPD7152 |
Approved |
0.6395 |
Remote Similarity |
NPD7520 |
Clinical (unspecified phase) |
0.6386 |
Remote Similarity |
NPD7509 |
Discontinued |
0.6383 |
Remote Similarity |
NPD7640 |
Approved |
0.6383 |
Remote Similarity |
NPD7639 |
Approved |
0.6333 |
Remote Similarity |
NPD6079 |
Approved |
0.6322 |
Remote Similarity |
NPD3574 |
Clinical (unspecified phase) |
0.6322 |
Remote Similarity |
NPD3618 |
Phase 1 |
0.6292 |
Remote Similarity |
NPD5328 |
Approved |
0.6282 |
Remote Similarity |
NPD4787 |
Phase 1 |
0.6282 |
Remote Similarity |
NPD7143 |
Approved |
0.6282 |
Remote Similarity |
NPD7144 |
Approved |
0.6279 |
Remote Similarity |
NPD4786 |
Approved |
0.6277 |
Remote Similarity |
NPD7638 |
Approved |
0.6265 |
Remote Similarity |
NPD6683 |
Phase 2 |
0.6235 |
Remote Similarity |
NPD3667 |
Approved |
0.6235 |
Remote Similarity |
NPD4223 |
Phase 3 |
0.6235 |
Remote Similarity |
NPD4221 |
Approved |
0.6207 |
Remote Similarity |
NPD5329 |
Approved |
0.619 |
Remote Similarity |
NPD4748 |
Discontinued |
0.6173 |
Remote Similarity |
NPD3703 |
Phase 2 |
0.6163 |
Remote Similarity |
NPD4788 |
Approved |
0.6154 |
Remote Similarity |
NPD6923 |
Approved |
0.6154 |
Remote Similarity |
NPD7087 |
Discontinued |
0.6154 |
Remote Similarity |
NPD7515 |
Phase 2 |
0.6154 |
Remote Similarity |
NPD6922 |
Approved |
0.6145 |
Remote Similarity |
NPD6115 |
Approved |
0.6145 |
Remote Similarity |
NPD6118 |
Approved |
0.6145 |
Remote Similarity |
NPD6114 |
Approved |
0.6145 |
Remote Similarity |
NPD6697 |
Approved |
0.61 |
Remote Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.6092 |
Remote Similarity |
NPD4197 |
Approved |
0.6087 |
Remote Similarity |
NPD4202 |
Approved |
0.6082 |
Remote Similarity |
NPD5211 |
Phase 2 |
0.6081 |
Remote Similarity |
NPD368 |
Approved |
0.6067 |
Remote Similarity |
NPD3573 |
Approved |
0.6022 |
Remote Similarity |
NPD7748 |
Approved |
0.6 |
Remote Similarity |
NPD4809 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD4758 |
Discontinued |
0.6 |
Remote Similarity |
NPD4808 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD4695 |
Discontinued |
0.5978 |
Remote Similarity |
NPD8034 |
Phase 2 |
0.5978 |
Remote Similarity |
NPD8035 |
Phase 2 |
0.596 |
Remote Similarity |
NPD5141 |
Approved |
0.5955 |
Remote Similarity |
NPD5690 |
Phase 2 |
0.5955 |
Remote Similarity |
NPD4688 |
Approved |
0.5955 |
Remote Similarity |
NPD4689 |
Approved |
0.5955 |
Remote Similarity |
NPD5205 |
Approved |
0.5955 |
Remote Similarity |
NPD4690 |
Approved |
0.5955 |
Remote Similarity |
NPD4138 |
Approved |
0.5955 |
Remote Similarity |
NPD4693 |
Phase 3 |
0.5952 |
Remote Similarity |
NPD3617 |
Approved |
0.5949 |
Remote Similarity |
NPD3699 |
Clinical (unspecified phase) |
0.5949 |
Remote Similarity |
NPD3700 |
Clinical (unspecified phase) |
0.5921 |
Remote Similarity |
NPD371 |
Approved |
0.5918 |
Remote Similarity |
NPD7632 |
Discontinued |
0.5909 |
Remote Similarity |
NPD3665 |
Phase 1 |
0.5909 |
Remote Similarity |
NPD385 |
Approved |
0.5909 |
Remote Similarity |
NPD3133 |
Approved |
0.5909 |
Remote Similarity |
NPD3666 |
Approved |
0.5909 |
Remote Similarity |
NPD384 |
Approved |
0.5904 |
Remote Similarity |
NPD6117 |
Approved |
0.5895 |
Remote Similarity |
NPD5222 |
Approved |
0.5895 |
Remote Similarity |
NPD5221 |
Approved |
0.5895 |
Remote Similarity |
NPD5220 |
Clinical (unspecified phase) |
0.5876 |
Remote Similarity |
NPD5286 |
Approved |
0.5876 |
Remote Similarity |
NPD4696 |
Approved |
0.5876 |
Remote Similarity |
NPD5285 |
Approved |
0.587 |
Remote Similarity |
NPD7136 |
Phase 2 |
0.5854 |
Remote Similarity |
NPD6113 |
Clinical (unspecified phase) |
0.5851 |
Remote Similarity |
NPD5771 |
Approved |
0.5844 |
Remote Similarity |
NPD3171 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD5173 |
Approved |
0.5833 |
Remote Similarity |
NPD4755 |
Approved |
0.5833 |
Remote Similarity |
NPD7902 |
Approved |
0.5833 |
Remote Similarity |
NPD6116 |
Phase 1 |
0.5824 |
Remote Similarity |
NPD4723 |
Approved |
0.5824 |
Remote Similarity |
NPD4722 |
Approved |
0.5816 |
Remote Similarity |
NPD5223 |
Approved |
0.5814 |
Remote Similarity |
NPD6928 |
Phase 2 |
0.5806 |
Remote Similarity |
NPD7637 |
Suspended |
0.5781 |
Remote Similarity |
NPD1799 |
Clinical (unspecified phase) |
0.5778 |
Remote Similarity |
NPD5280 |
Approved |
0.5778 |
Remote Similarity |
NPD4694 |
Approved |
0.5773 |
Remote Similarity |
NPD5290 |
Discontinued |
0.5773 |
Remote Similarity |
NPD4225 |
Approved |
0.5769 |
Remote Similarity |
NPD4224 |
Phase 2 |
0.5765 |
Remote Similarity |
NPD5364 |
Discontinued |
0.5761 |
Remote Similarity |
NPD7285 |
Clinical (unspecified phase) |
0.5761 |
Remote Similarity |
NPD4753 |
Phase 2 |
0.5758 |
Remote Similarity |
NPD5226 |
Approved |
0.5758 |
Remote Similarity |
NPD4633 |
Approved |
0.5758 |
Remote Similarity |
NPD5224 |
Approved |
0.5758 |
Remote Similarity |
NPD5225 |
Approved |
0.5747 |
Remote Similarity |
NPD4692 |
Approved |
0.5747 |
Remote Similarity |
NPD4139 |
Approved |
0.5745 |
Remote Similarity |
NPD6399 |
Phase 3 |
0.5732 |
Remote Similarity |
NPD4732 |
Discontinued |
0.573 |
Remote Similarity |
NPD3668 |
Phase 3 |
0.5729 |
Remote Similarity |
NPD4697 |
Phase 3 |
0.5714 |
Remote Similarity |
NPD4700 |
Approved |
0.57 |
Remote Similarity |
NPD5175 |
Approved |
0.57 |
Remote Similarity |
NPD5174 |
Approved |
0.5694 |
Remote Similarity |
NPD342 |
Phase 1 |
0.5679 |
Remote Similarity |
NPD4244 |
Approved |
0.5679 |
Remote Similarity |
NPD4245 |
Approved |
0.5679 |
Remote Similarity |
NPD4789 |
Approved |
0.5673 |
Remote Similarity |
NPD4634 |
Approved |
0.5667 |
Remote Similarity |
NPD1696 |
Phase 3 |
0.5657 |
Remote Similarity |
NPD5344 |
Discontinued |
0.5638 |
Remote Similarity |
NPD5284 |
Approved |
0.5638 |
Remote Similarity |
NPD5281 |
Approved |
0.5631 |
Remote Similarity |
NPD6899 |
Approved |
0.5631 |
Remote Similarity |
NPD6881 |
Approved |
0.5625 |
Remote Similarity |
NPD6705 |
Phase 1 |
0.5625 |
Remote Similarity |
NPD4629 |
Approved |
0.5625 |
Remote Similarity |
NPD5210 |
Approved |
0.561 |
Remote Similarity |
NPD6081 |
Approved |
0.5604
|
Remote Similarity |
NPD6098 |
Approved |